| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| aphrodisiac |
Is a |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Tranquilizer |
Is a |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Anti-psychotic agent (substance) |
Is a |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Antidepressant (substance) |
Is a |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Anxiolytic, sedative AND/OR hypnotic (substance) |
Is a |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Sedative/neuroleptic |
Is a |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Anxiolytic, sedative AND/OR hypnotic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| médicament neuroleptique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing tryptophan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing lithium carbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing lithium citrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Medicinal product acting as hypnotic (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Remoxipride hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Antipsychotic depot injections |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing lithium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Lithium carbonate 520mg/5mL sugar free liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Lithium carbonate 200mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Lithium carbonate 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Lithium carbonate 450mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Lithium carbonate 400mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Lithium citrate 520mg/5mL s/f oral liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing precisely lithium citrate 101.8 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing precisely lithium citrate 203.6 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Viloxazine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Compound antidepressants |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing precisely fluphenazine hydrochloride 1.5 milligram and nortriptyline 30 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing precisely fluphenazine hydrochloride 500 microgram and nortriptyline 10 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing precisely amitriptyline 25 milligram and perphenazine 2 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing precisely amitriptyline 10 milligram and perphenazine 2 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Other antidepressant drugs |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing precisely phenobarbital 15 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing precisely phenobarbital 30 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing precisely phenobarbital 60 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing precisely phenobarbital 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| phénobarbital sodique 200 mg/mL, ampoule de 1 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing precisely phenobarbital 3 milligram/1 milliliter conventional release oral elixir (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Anxiolytics and neuroleptic perioperative drugs |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Phenobarbital sodium 15mg/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Phenobarbital sodium 30mg/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Phenobarbital sodium 60mg/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing viloxazine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing remoxipride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Non-barbiturate hypnotic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Medicinal product acting as antidepressant agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Psychotropic agent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Lithium carbonate 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing precisely lithium carbonate 300 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Lithium carbonate cr 450mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Phenobarbital sodium 65mg/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Phenobarbital sodium 130mg/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Parenteral paraldehyde injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Phenobarbital 16 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Phenobarbital 16.2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Phenobarbital 90 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Phenobarbital 16 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Phenobarbital 20mg/5mL elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Lithium carbonate m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Lithotab 300mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing paraldehyde in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Rectal paraldehyde liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Amitriptyline hydrochloride+perphenazine 10mg/4mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing precisely amitriptyline 25 milligram and perphenazine 4 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing precisely amitriptyline 50 milligram and perphenazine 4 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing triazolopyridine (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Oral phenobarbital |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Parenteral phenobarbital |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Dihydroergotoxine mesilate |
Is a |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Barbiturate hypnotic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Sodium oxybate 500 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Psychotherapeutic agent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing phenobarbital (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Antimanic agent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Anxiolytic agent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing belladonna alkaloids and ergotamine tartrate and phenobarbital |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Medicinal product acting as anxiolytic agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Phenobarbital-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Phenobarbital-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Anxiolytics |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Lithium carbonate 520mg/5mL sugar free liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Sodium oxybate (substance) |
Is a |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Lithium carbonate (substance) |
Is a |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Lithium citrate (substance) |
Is a |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Dihydroergotamine mesilate |
Is a |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Product containing belladonna alkaloid and phenobarbital (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
| Mood stabilizing agent |
Is a |
False |
Psychotherapeutic agent |
Inferred relationship |
Some |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]